Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

320.50p
   
  • Change Today:
      0.50p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 52,899
  • Market Cap: £320.50m
  • RiskGrade: 125

Oxford Biomedica says Sanofi pulling out of haemophilia project

By Frank Prenesti

Date: Friday 19 Mar 2021

LONDON (ShareCast) - (Sharecast News) - Oxford Biomedica said that Sanofi's decision to terminate collaboration on a haemophilia treatment would have a "negligible" impact on revenue.
Sanofi had given notice to "terminate the collaboration and license agreement for process development and manufacturing of lentiviral vectors to treat haemophilia", Oxford said on Friday.

"The group expects that the impact on revenue will be negligible over the coming 24 month period."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 320.50p
Change Today 0.50p
% Change 0.16 %
52 Week High 470.00
52 Week Low 166.80
Volume 52,899
Shares Issued 100.00m
Market Cap £320.50m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
26.86% below the market average26.86% below the market average26.86% below the market average26.86% below the market average26.86% below the market average
21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average
Price Trend
2.2% below the market average2.2% below the market average2.2% below the market average2.2% below the market average2.2% below the market average
51.85% above the sector average51.85% above the sector average51.85% above the sector average51.85% above the sector average51.85% above the sector average
Income Not Available
Growth
52.07% below the market average52.07% below the market average52.07% below the market average52.07% below the market average52.07% below the market average
58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 6
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 15-May-2024

Time Volume / Share Price
10:43 60 @ 320.50p
10:26 624 @ 321.00p
10:26 531 @ 321.00p
10:26 562 @ 321.00p
10:26 938 @ 321.00p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page